436
Views
18
CrossRef citations to date
0
Altmetric
Report

Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment

, MD, , BSc, , MD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Stephanie K. Rubel, Matthew Eisenstat, Jessica Wolff, Michael Calevski & Sasha Mital. (2023) Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review. Substance Use & Misuse 58:5, pages 685-697.
Read now
Andrea G. Barthwell, Jeffrey Allgaier & Kenneth Egli. (2018) Definitive urine drug testing in office-based opioid treatment: a literature review. Critical Reviews in Toxicology 48:10, pages 815-838.
Read now
Nusrat Rahman, Abhilash Janardhanan, Sahil Shikalgar, Mohammad Aslam Pirkhan, James Canner, Christopher Skipwith & Md. Noor-E-Alam. Investigation of Simulated Adherence in Long-Term Buprenorphine/Naloxone Treatment Patients. Substance Use & Misuse 0:0, pages 1-5.
Read now

Articles from other publishers (15)

Rebekah Rollston, Barbara Burke, Scott G. Weiner, Winifred Gallogly, Apryl D. Brandon, Robyn Carter & Brian Clear. (2023) Evaluation of urine drug screen falsification of results among patients with opioid use disorder receiving treatment in a telehealth model of care. Journal of Substance Use and Addiction Treatment 154, pages 209151.
Crossref
Jarratt D. Pytell, Penn Whitley, Steven D. Passik, William L. Bundy, Eric Dawson & Brendan Saloner. (2023) Association of Patients’ Direct Addition of Buprenorphine to Urine Drug Test Specimens With Clinical Factors in Opioid Use Disorder. JAMA Psychiatry 80:5, pages 459.
Crossref
Stuart Farquharson, Chetan Shende, Jenelle Newcomb, Ismene L. Petrakis & Albert J. Arias. (2023) Analysis of Drugs in Saliva of US Military Veterans Treated for Substance Use Disorders Using Supported Liquid Extraction and Surface-Enhanced Raman Spectral Analysis. Molecules 28:5, pages 2010.
Crossref
Hiroko Furo, Tony Lin, Yi Yuan Zhou & Sarah Abdelsayed. 2023. Advances and Challenges in Urine Laboratory Analysis [Working Title]. Advances and Challenges in Urine Laboratory Analysis [Working Title].
Hiroko Furo, Timothy Wiegand, Meenakshi Rani, Diane G Schwartz, Ross W Sullivan & Peter L Elkin. (2023) Association Between Buprenorphine Dose and the Urine “Norbuprenorphine” to “Creatinine” Ratio: Revised. Substance Abuse: Research and Treatment 17, pages 117822182311537.
Crossref
Xiaoyue Shan, Chengjian Cao & Bingsheng Yang. (2022) Analytical Approaches for the Determination of Buprenorphine, Methadone and Their Metabolites in Biological Matrices. Molecules 27:16, pages 5211.
Crossref
Hiroko Furo, Diane G Schwartz, Ross W Sullivan & Peter L Elkin. (2021) Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program. Substance Abuse: Research and Treatment 15, pages 117822182110617.
Crossref
Christopher Tremonti & Paul S. Haber. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment 637 654 .
Jill S. Warrington, Kaitlyn Booth, Gregory S. Warrington & Samuel Francis-Fath. (2020) Use of urinary naloxone levels in a single provider practice: a case study. Addiction Science & Clinical Practice 15:1.
Crossref
Jill S. Warrington, Gregory S. Warrington, Samuel Francis-Fath & John Brooklyn. (2020) Urinary Buprenorphine, Norbuprenorphine and Naloxone Concentrations and Ratios: Review and Potential Clinical Implications. Journal of Addiction Medicine 14:6, pages e344-e349.
Crossref
Jaime R. Ransohoff, Athena K. Petrides, Greg J. Piscitello, James G. Flood & Stacy E.F. Melanson. (2019) Urine is superior to oral fluid for detecting buprenorphine compliance in patients undergoing treatment for opioid addiction. Drug and Alcohol Dependence 203, pages 8-12.
Crossref
Lewei (Allison) Lin, Michelle R. Lofwall, Sharon L. Walsh, Adam J. Gordon & Hannah K. Knudsen. (2018) Perceptions and practices addressing diversion among US buprenorphine prescribers. Drug and Alcohol Dependence 186, pages 147-153.
Crossref
Stephen R. Holt, Joseph H. Donroe, Dana A. Cavallo & Jeanette M. Tetrault. (2018) Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder. Drug and Alcohol Dependence 186, pages 171-174.
Crossref
Anthony J. Accurso, Joshua D. Lee & Jennifer McNeely. (2017) High prevalence of urine tampering in an office-based opioid treatment practice detected by evaluating the norbuprenorphine to buprenorphine ratio. Journal of Substance Abuse Treatment 83, pages 62-67.
Crossref
Stephanie K. Rubel, Matthew Eisenstat, Jessica Wolff, Michael Calevski & Sasha Mital. (2022) Scope of, Motivations for, And Outcomes of Diverted Buprenorphine Among People Using Buprenorphine: A Scoping Review. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.